SHARON MEYER: Open Payments
NPI 1427456318 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 48 payments from 15 companies in 2025. Trend: 2023 $591 · 2024 $1,964 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $299 |
| Janssen Biotech, Inc. | 5 | $204 |
| Ardelyx, Inc. | 4 | $130 |
| Madrigal Pharmaceuticals | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Ipsen Biopharmaceuticals, Inc | 3 | $90 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| QOL Medical, LLC | 2 | $53 |
| PFIZER INC. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
Products named: TREMFYA, RINVOQ, IBSRELA, REZDIFFRA, IQIRVO, ENTYVIO, LINZESS, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
